When was NorthStar Medical Radioisotopes founded?

NorthStar Medical Radioisotopes was founded in 2006 and raised its 1st funding round 4 years after it was founded.

Where is NorthStar Medical Radioisotopes located?

NorthStar Medical Radioisotopes is headquartered in Madison, United States.

Who is the current CEO of NorthStar Medical Radioisotopes?

George Messina of NorthStar Medical Radioisotopes.

How many employees does NorthStar Medical Radioisotopes have?

As of Jul 31, 2026, the latest employee count at NorthStar Medical Radioisotopes is 320.

Is NorthStar Medical Radioisotopes a funded company?

NorthStar Medical Radioisotopes is a funded company, having raised a total of $15.1M across 18 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Mar 11, 2010.

When was the latest funding round of NorthStar Medical Radioisotopes?

NorthStar Medical Radioisotopes' latest funding was a $***** Grant (prize money) round on May 13, 2025, with participation from 1 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $1.23B in funding in 2026 to date.

Where does NorthStar Medical Radioisotopes rank among its competitors?

NorthStar Medical Radioisotopes ranks 2nd amongst 29 active competitors, of which 6 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was NorthStar Medical Radioisotopes, which secured $10.7M in May, 2025.

Who are the top competitors of NorthStar Medical Radioisotopes?

NorthStar Medical Radioisotopes' top competitors include Curium, ARTMS and AZI. Among them, NorthStar Medical Radioisotopes secured the most recent funding round in May, 2025.

NorthStar Medical Radioisotopes - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market. Its patented technologies include innovative non-uranium-based molybdenum-99 production methods, a novel separation chemistry system, and tools for the nuclear medicine market. Products include Non-HEU 99-Molybdenum and RadioGenix intelligent isotope separation system. Claims to be the first domestic producer of 99-Molybdenum and the only supplier of Non-HEU material.

Key Metrics

Founded Year

2006

Location

Madison, United States

Stage

Series B

Total Funding

$15.1M in 18 rounds

Latest Funding Round

Grant (prize money), May 13, 2025, $*****

Investors

Hendricks Holding & 5 more

Ranked

2^nd among 29 active competitors

Employee Count

320 as on Jul 31, 2026

Similar Companies

Curium & 32 more

View NorthStar Medical Radioisotopes' full profile

NorthStar Medical Radioisotopes has raised a total funding of $15.1M over 18 rounds. Its first funding round was on Mar 11, 2010. Its latest funding round was a Grant (prize money) round on May 13, 2025 for $*****. 1 investor participated in its latest round. NorthStar Medical Radioisotopes has 6 institutional investors.

Here is the list of recent funding rounds of NorthStar Medical Radioisotopes:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 13, 2025	5986861	Grant (prize money)	7002187	6498305	4578828	1907091
Jul 23, 2019	5336818	Grant (prize money)	6060286	6419296	7424108	DOE
Apr 23, 2019	8838896	Conventional Debt	3725626	1000070	6340337	Oberland Capital

Access funding benchmarks and valuations. Sign up today!

View details of NorthStar Medical Radioisotopes's funding rounds and investors

The founders of NorthStar Medical Radioisotopes is George Messina.

Here are the details of NorthStar Medical Radioisotopes' key team members:

George Messina: Co-Founder & CEO of NorthStar Medical Radioisotopes.

View details of NorthStar Medical Radioisotopes's Founder profiles and Board Members

NorthStar Medical Radioisotopes' employee count trend

NorthStar Medical Radioisotopes has 320 employees as of Jul 26. Here is NorthStar Medical Radioisotopes's employee count trend over the years:

Employee count trend for NorthStar Medical Radioisotopes

Uncover NorthStar Medical Radioisotopes' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of NorthStar Medical Radioisotopes include Curium, ARTMS and AZI. Here is the list of Top 10 competitors of NorthStar Medical Radioisotopes, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Curium 2017, Paris (France), Seed	Specialty developer, manufacturer & distributor of radiopharmaceuticals	-	CapVest, Ardian	58/100
2nd	NorthStar Medical Radioisotopes 2006, Madison (United States), Series B	Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market	$15.1M	Oberland Capital, Foley Ventures & 4 others	58/100
3rd	ARTMS 2013, Vancouver (Canada), Acquired	Provider and developer of radioisotope technologies	$26.6M	Deerfield, Quark Venture & 3 others	46/100
4th	AZI 2017, Bunker Hill (United States), Series C	Developer of radiopharmaceuticals for imaging purposes	$58.3M	-	42/100
5th	Ground Fluor Pharmaceuticals 2012, Lincoln (United States), Series A	Biomedical company developing proprietary new chemistry for the synthesis of pharmaceutical compounds	-	Nebraska, America’s Seed Fund & 2 others	37/100
6th	Am Chemicals 2003, Oceanside (United States), Unfunded	Oligonucleotide synthesis solutions: solid supports, reagents, and expert services	-	-	33/100
7th	CellBion 2010, Seoul (South Korea), Public	Radioactive probes for imaging	-	M Venture Investment, BNH INVESTMENT & 2 others	33/100
8th	Nanovista 2015, Toronto (Canada), Seed	Developing multimodal visualization agents	$2.3M	JLABS, GreenSky	32/100
9th	Alsachim 2005, Illkirch Graffenstaden (France), Acquired	Custom synthesis of stable radioisotopes & analytical services for pharmaceutical and biotech companies	-	Naxicap	31/100
10th	VNIR 2017, Bengaluru (India), Seed	Developer of infra red fluorescence based diagnostic molecules	$724K	C-CAMP, BIRAC & 40 others	30/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on NorthStar Medical Radioisotopes's competitors? Click here to see the top ones

NorthStar Medical Radioisotopes has made no investments or acquisitions yet.

Here is the latest report on NorthStar Medical Radioisotopes's sector:

Free

Life Sciences Platforms and Tools - Sector Report

Edition: June, 2026 (73 Pages)

View all reports related to NorthStar Medical Radioisotopes

Media has covered NorthStar Medical Radioisotopes for a total of 11 events in the last 1 year, 4 of them have been about partnerships and 3 about people movement.